India Digital Diabetes Management Market
India Digital Diabetes Management Market Size More Than Doubles to Reach USD 1.1 Billion by 2029
Published | 31 May 2023
The India digital diabetes management market is gaining traction because of the advent of artificial intelligence (AI) in diabetes care devices and increasing number of diabetes patients.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the India digital diabetes management market size at USD 477.06 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the India digital diabetes management market size to grow at an impressive CAGR of 12.99% reaching a value of USD 1,114 million by 2029. The rising incidence of diabetes as well as the expanding use of innovative technologies like smartwatches for improved management of chronic illnesses are significant growth drivers for the India digital diabetes management market. The market for digital diabetes management in India is expected to grow at a rapid rate due to the growing number of domestic healthcare organizations and brands offering this service.
India Digital Diabetes Management Market – Overview
According to the definition by the World Health Organization (WHO), diabetes is a chronic condition brought on by either insufficient insulin production by the pancreas or inefficient insulin utilization by the body. A hormone called insulin controls blood sugar levels. The following six technologies have the potential to revolutionize diabetes care: telehealth, qualitative hypoglycemia alarms, artificial intelligence (AI), cybersecurity of diabetes devices, diabetes registries, and the incorporation of digital diabetes data into the electronic health record (EHR).
India Digital Diabetes Management Market – By End Use
Based on end use, the India digital diabetes management market is segmented into hospitals, home settings, and diagnostic centers. The home settings segment account for the largest market share as these digital diabetes management as such technologies allow diabetes patients and caregivers to manage their illnesses efficiently in the absence of medical professionals. The use of digital diabetes management devices and apps helps patients take their doses routinely as well as constantly track their glucose levels to eliminate the risk of emergencies.
Impact of COVID-19 on India Digital Diabetes Management Market
The unprecedented COVID-19 pandemic offered immense growth opportunities to the India digital diabetes management market. Several studies conducted during the pandemic revealed that diabetes patients are more prone to get severe COVID-19 problems. The pancreas, which is the organ that produces insulin, may be directly attacked by COVID. Blood glucose (sugar) levels may rise and the body's metabolic pathways for metabolizing glucose may shift as a result of inflammation in the body during COVID. However, patient visits to healthcare facilities during the lockdown declined owing to the high risk of cross-contamination. It resulted in a significant spike in digital diabetes management technologies for better remote patient monitoring.
Major players operating in India digital diabetes management market include Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd., Bayer AG, Lifescan, Inc., Dexcom, Inc., Sanofi, Insulet Corporation, Ascensia Diabetes Care Holdings Ag, and B Braun Melsungen AG. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the India Digital Diabetes Management Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the India Digital Diabetes Management Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation from scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
- India Digital Diabetes Management Market - By Product (Smart Glucose Meter, Continuous Blood Glucose Monitoring System, Smart Insulin Pens, Smart Insulin Pumps, Apps); By Device (Wearable Devices, Handheld Devices); By End Use (Hospitals, Home Settings, Diagnostic Centers); By Region (North India, South India, East India, West India), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
Publish Date: May 2023
Advent of artificial intelligence (AI) in diabetes care devices and an increasing number of diabetes patients are expected to boost the growth of India digital diabetes management market during the forecast period between 2023 and 2029.
Relevant Press Releases
- Global Pacemakers Market Thriving: Projected to touch USD 5.4 Billion by 2027, growing at the CAGR of 3 % during the forecast period (2021-2027)
- India Digital Diabetes Management Market Size More Than Doubles to Reach USD 1.1 Billion by 2029
- Global E-Prescribing Solutions Market Size Zooming More Than 5X to Touch USD 13.8 Billion by 2029
- Healthcare Supply Chain Management Market to Grow at a CAGR of 13.2% during Forecast Period
- Global Biosimilars Market Size Zooming to Touch USD 115.4 Billion by 2029